Difficulty: Medium
Average Score: 64%
Practice
This agent is the drug of choice in severe amebic disease and for hepatic abscess. It is activated to toxic intermediates by the pyruvate - ferredoxin oxidoreductase enzyme system present in the parasite.
Correct answer
D
Rationale
The correct answer is D) Metronidazole. Metronidazole is the drug of choice for severe amebic disease and hepatic abscess because it is activated to toxic intermediates specifically by the pyruvate-ferredoxin oxidoreductase enzyme system present in the parasite. This mechanism of action targets the parasite while sparing host cells, making it an effective treatment for these conditions.
Option A) Diloxanide furoate is used for asymptomatic cyst passers in Entamoeba histolytica infection, not for severe cases like hepatic abscesses. Option B) Emetine is an anti-amebic agent but is not the drug of choice for severe amebic disease or hepatic abscess. Option C) Iodoquinol is used for intestinal amebiasis but not for severe cases involving hepatic abscesses.
Understanding the specific drug of choice for different stages and severities of parasitic infections is crucial for healthcare professionals to provide appropriate and effective treatment. By grasping the mechanisms of action of these drugs, clinicians can make informed decisions to combat parasitic diseases effectively while minimizing side effects and maximizing therapeutic outcomes.
Option A) Diloxanide furoate is used for asymptomatic cyst passers in Entamoeba histolytica infection, not for severe cases like hepatic abscesses. Option B) Emetine is an anti-amebic agent but is not the drug of choice for severe amebic disease or hepatic abscess. Option C) Iodoquinol is used for intestinal amebiasis but not for severe cases involving hepatic abscesses.
Understanding the specific drug of choice for different stages and severities of parasitic infections is crucial for healthcare professionals to provide appropriate and effective treatment. By grasping the mechanisms of action of these drugs, clinicians can make informed decisions to combat parasitic diseases effectively while minimizing side effects and maximizing therapeutic outcomes.